FibroGen Alpha and Beta Analysis
| FGENDelisted Stock | USD 9.22 0.29 3.05% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as FibroGen. It also helps investors analyze the systematic and unsystematic risks associated with investing in FibroGen over a specified time horizon. Remember, high FibroGen's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to FibroGen's market risk premium analysis include:
Beta (0.29) | Alpha (0.20) | Risk 4.49 | Sharpe Ratio (0.06) | Expected Return (0.28) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
FibroGen |
FibroGen Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. FibroGen market risk premium is the additional return an investor will receive from holding FibroGen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in FibroGen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate FibroGen's performance over market.| α | -0.2 | β | -0.29 |
FibroGen Fundamentals Vs Peers
Comparing FibroGen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze FibroGen's direct or indirect competition across all of the common fundamentals between FibroGen and the related equities. This way, we can detect undervalued stocks with similar characteristics as FibroGen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of FibroGen's fundamental indicators could also be used in its relative valuation, which is a method of valuing FibroGen by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare FibroGen to competition |
| Fundamentals | FibroGen | Peer Average |
| Return On Equity | -10.16 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Profit Margin | 25.99 % | (1.27) % |
| Operating Margin | (4.99) % | (5.51) % |
| Current Valuation | 86.86 M | 16.62 B |
| Shares Outstanding | 4.05 M | 571.82 M |
| Shares Owned By Insiders | 1.65 % | 10.09 % |
FibroGen Opportunities
FibroGen Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Will FibroGen Inc. stock keep raising dividends - July 2025 PostEarnings Risk Managed Trade Strategies - fcp.pa.gov.br | 11/05/2025 |
2 | FibroGen Q3 Earnings Snapshot | 11/10/2025 |
3 | FibroGen Inc Q3 2025 Earnings Call Highlights Strategic Moves Bolster Financial ... | 11/11/2025 |
4 | FibroGen, Inc. Q3 2025 Earnings Call Transcript | 11/12/2025 |
5 | Acquisition by Thane Wettig of 2700 shares of FibroGen at 9.0999 subject to Rule 16b-3 | 11/17/2025 |
6 | UCSF buys former biotech headquarters in Mission Bay expansion | 12/17/2025 |
7 | FibroGen Faces Option Delistings as of January 8th - GuruFocus | 01/08/2026 |
About FibroGen Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including FibroGen or other delisted stocks. Alpha measures the amount that position in FibroGen has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
FibroGen Upcoming Company Events
As portrayed in its financial statements, the presentation of FibroGen's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, FibroGen's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of FibroGen's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of FibroGen. Please utilize our Beneish M Score to check the likelihood of FibroGen's management manipulating its earnings.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with FibroGen
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in FibroGen Stock
If you are still planning to invest in FibroGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FibroGen's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |